Prozone Effect in the Diagnosis of Lupus Anticoagulant for the Lupus Anticoagulant-Hypoprothrombinemia Syndrome.
暂无分享,去创建一个
[1] Ji Soo Kim,et al. Pulmonary hemorrhage in pediatric lupus anticoagulant hypoprothrombinemia syndrome , 2014, Korean journal of pediatrics.
[2] L. Lingappa,et al. Variable Manifestations of Severe Hypoprothrombinemia (Factor II Deficiency): 2 Cases , 2014 .
[3] A. Tripodi,et al. More on: laboratory investigation of lupus anticoagulants: mixing studies are sometimes required , 2011, Journal of thrombosis and haemostasis : JTH.
[4] G. Kershaw,et al. Laboratory investigation of lupus anticoagulants: mixing studies are sometimes required , 2010, Journal of thrombosis and haemostasis : JTH.
[5] V. Baca,et al. Diagnosis of lupus anticoagulant in the lupus anticoagulant‐hypoprothrombinemia syndrome: Report of two cases and review of the literature , 2002, American journal of hematology.
[6] M. Lockshin,et al. Lupus anticoagulant–hypoprothrombinemia syndrome associated with systemic lupus erythematosus: report of 2 cases and review of literature , 1999, Lupus.
[7] G. Finazzi,et al. Severe bleeding due to acquired hypoprothrombinemia-lupus anticoagulant syndrome. Case report and review of literature. , 1997, Haematologica.
[8] Joan Hadzi-Nesic,et al. Transient hemorrhagic diathesis associated with an inhibitor of prothrombin with lupus anticoagulant in a 1½‐year‐old girl: Report of a case and review of the literature , 1996, American journal of hematology.
[9] E. Silverman,et al. Hypoprothrombinemia in childhood systemic lupus erythematosus. , 1994, Seminars in arthritis and rheumatism.
[10] D. Triplett,et al. A Hexagonal (II) Phase Phospholipid Neutralization Assay for Lupus Anticoagulant Identification , 1993, Thrombosis and Haemostasis.
[11] T. Barbui,et al. Lupus Anticoagulant IgG's (LA) Are Not Directed to Phospholipids only, but to a Complex of Lipid-Bound Human Prothrombin , 1991, Thrombosis and Haemostasis.
[12] R. Hift,et al. Acquired hypoprothrombinaemia and lupus anticoagulant: response to steroid therapy. , 1991, British journal of rheumatology.
[13] A. Janoff,et al. Distinguishing Plasma Lupus Anticoagulants from Anti-Factor Antibodies Using Hexagonal (II) Phase Phospholipids , 1989, Thrombosis and Haemostasis.
[14] P. Cullis,et al. Human hybridoma lupus anticoagulants distinguish between lamellar and hexagonal phase lipid systems. , 1986, The Journal of biological chemistry.
[15] Y. Et,et al. Purification and kinetic studies on a circulating anticoagulant in a suspected case of lupus erythematosus. , 1965 .
[16] L. Gaston,et al. Purification and Kinetic Studies on a Circulating Anticoagulant in a Suspected Case of Lupus Erythematosus* , 1965, Thrombosis and Haemostasis.
[17] A. Loeliger,et al. Prothrombin as Co-Factor of the Circulating Anticoagulant in Systemic Lupus Erythematosus? , 1959, Thrombosis and Haemostasis.